BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 21297299)

  • 1. Development of an efficient transdermal delivery system of small interfering RNA using functional peptides, Tat and AT-1002.
    Uchida T; Kanazawa T; Takashima Y; Okada H
    Chem Pharm Bull (Tokyo); 2011; 59(2):196-201. PubMed ID: 21297299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects on atopic dermatitis by anti-RelA short interfering RNA combined with functional peptides Tat and AT1002.
    Uchida T; Kanazawa T; Kawai M; Takashima Y; Okada H
    J Pharmacol Exp Ther; 2011 Aug; 338(2):443-50. PubMed ID: 21531792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Liquid Crystal Formulation that Can Penetrate the Stratum Corneum for Intradermal Delivery of Small Interfering RNA.
    Kawai M; Ibaraki H; Takashima Y; Kanazawa T; Okada H
    Mol Pharm; 2021 Mar; 18(3):1038-1047. PubMed ID: 33395310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an Innovative Intradermal siRNA Delivery System Using a Combination of a Functional Stearylated Cytoplasm-Responsive Peptide and a Tight Junction-Opening Peptide.
    Ibaraki H; Kanazawa T; Takashima Y; Okada H; Seta Y
    Molecules; 2016 Sep; 21(10):. PubMed ID: 27669207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal anti-nuclear kappaB siRNA therapy for atopic dermatitis using a combination of two kinds of functional oligopeptide.
    Ibaraki H; Kanazawa T; Takashima Y; Okada H; Seta Y
    Int J Pharm; 2018 May; 542(1-2):213-220. PubMed ID: 29551748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-RelA siRNA-Encapsulated Flexible Liposome with Tight Junction-Opening Peptide as a Non-invasive Topical Therapeutic for Atopic Dermatitis.
    Ibaraki H; Kanazawa T; Kurano T; Oogi C; Takashima Y; Seta Y
    Biol Pharm Bull; 2019; 42(7):1216-1225. PubMed ID: 31257297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming thickened pathological skin in psoriasis via iontophoresis combined with tight junction-opening peptide AT1002 for intradermal delivery of NF-κB decoy oligodeoxynucleotide.
    Fukuta T; Tanaka D; Inoue S; Michiue K; Kogure K
    Int J Pharm; 2021 Jun; 602():120601. PubMed ID: 33905867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of AT1002 on the delivery of ritonavir in the presence of bioadhesive polymer, carrageenan.
    Song KH; Eddington ND
    Arch Pharm Res; 2012 May; 35(5):937-43. PubMed ID: 22644862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles.
    Kanazawa T; Akiyama F; Kakizaki S; Takashima Y; Seta Y
    Biomaterials; 2013 Dec; 34(36):9220-6. PubMed ID: 23992922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the six-mer synthetic peptide (AT1002) fragment of zonula occludens toxin on the intestinal absorption of cyclosporin A.
    Song KH; Fasano A; Eddington ND
    Int J Pharm; 2008 Mar; 351(1-2):8-14. PubMed ID: 17954018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paracellular permeation-enhancing effect of AT1002 C-terminal amidation in nasal delivery.
    Song KH; Kim SB; Shim CK; Chung SJ; Kim DD; Rhee SK; Choi GJ; Kim CH; Kim K
    Drug Des Devel Ther; 2015; 9():1815-23. PubMed ID: 25848218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple, noninvasive and efficient method for transdermal delivery of siRNA.
    Lin CM; Huang K; Zeng Y; Chen XC; Wang S; Li Y
    Arch Dermatol Res; 2012 Mar; 304(2):139-44. PubMed ID: 22009459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting neuronal nitric oxide synthase by a cell penetrating peptide Tat-LK15/siRNA bioconjugate.
    Peng J; Rao Y; Yang X; Jia J; Wu Y; Lu J; Tao Y; Tu W
    Neurosci Lett; 2017 May; 650():153-160. PubMed ID: 28450191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research progress in transdermal delivery for small interfering RNA].
    Chen Y; Xu N; Hu Z
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):622-631. PubMed ID: 32347057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an antisense RNA delivery system using conjugates of the MS2 bacteriophage capsids and HIV-1 TAT cell-penetrating peptide.
    Wei B; Wei Y; Zhang K; Wang J; Xu R; Zhan S; Lin G; Wang W; Liu M; Wang L; Zhang R; Li J
    Biomed Pharmacother; 2009 May; 63(4):313-8. PubMed ID: 18823738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zonula occludens toxin synthetic peptide derivative AT1002 enhances in vitro and in vivo intestinal absorption of low molecular weight heparin.
    Motlekar NA; Fasano A; Wachtel MS; Youan BB
    J Drug Target; 2006 Jun; 14(5):321-9. PubMed ID: 16882552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical delivery of siRNA into skin using SPACE-peptide carriers.
    Chen M; Zakrewsky M; Gupta V; Anselmo AC; Slee DH; Muraski JA; Mitragotri S
    J Control Release; 2014 Apr; 179():33-41. PubMed ID: 24434423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the Fractional Laser Still Effective in Assisting Cutaneous Macromolecule Delivery in Barrier-Deficient Skin? Psoriasis and Atopic Dermatitis as the Disease Models.
    Lee WR; Shen SC; Sung CT; Liu PY; Fang JY
    Pharm Res; 2018 Apr; 35(7):128. PubMed ID: 29700662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of electronic-neutral penetrating peptides cyclosporin A to deliver pro-apoptotic peptide: A possibly better choice than positively charged TAT.
    Gao W; Yang X; Lin Z; He B; Mei D; Wang D; Zhang H; Zhang H; Dai W; Wang X; Zhang Q
    J Control Release; 2017 Sep; 261():174-186. PubMed ID: 28662902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel amphiphilic lipid augments the co-delivery of erlotinib and IL36 siRNA into the skin for psoriasis treatment.
    Boakye CHA; Patel K; Doddapaneni R; Bagde A; Marepally S; Singh M
    J Control Release; 2017 Jan; 246():120-132. PubMed ID: 27170227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.